During the past decade, Hemophilia Outreach Center Green Bay conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hemophilia Outreach Center Green Bay" #1 collaborator was "Takeda" with 2 trials as a collaborator, "BioMarin Pharmaceutical" with 1 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hemophilia of Georgia, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hemophilia Outreach Center Green Bay" are "Hemophilia" (2 trials), "Von Willebrand Diseases" (2 trials), "Bleeding Disorder" (1 trials), "Connective Tissue Disorder" (1 trials) and "Haemophilia" (1 trials). Many other conditions were trialed in "Hemophilia Outreach Center Green Bay" in a lesser frequency.

The vast majority of trials in "Hemophilia Outreach Center Green Bay" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hemophilia Outreach Center Green Bay". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hemophilia Outreach Center Green Bay, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hemophilia Outreach Center Green Bay, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".